- Home
- RGNX vs GAU Comparison
RGNX vs GAU Comparison
Compare RGNX & GAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- GAU
- Stock Information
- Founded
- RGNX 2008
- GAU 1999
- Country
- RGNX United States
- GAU Canada
- Employees
- RGNX N/A
- GAU N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- GAU
- Sector
- RGNX Health Care
- GAU
- Exchange
- RGNX Nasdaq
- GAU Nasdaq
- Market Cap
- RGNX 387.0M
- GAU 342.0M
- IPO Year
- RGNX 2015
- GAU N/A
- Fundamental
- Price
- RGNX $9.49
- GAU $1.44
- Analyst Decision
- RGNX Strong Buy
- GAU Strong Buy
- Analyst Count
- RGNX 8
- GAU 1
- Target Price
- RGNX $31.75
- GAU $2.80
- AVG Volume (30 Days)
- RGNX 1.3M
- GAU 967.1K
- Earning Date
- RGNX 07-31-2025
- GAU 05-14-2025
- Dividend Yield
- RGNX N/A
- GAU N/A
- EPS Growth
- RGNX N/A
- GAU N/A
- EPS
- RGNX N/A
- GAU N/A
- Revenue
- RGNX $156,718,000.00
- GAU $276,234,000.00
- Revenue This Year
- RGNX $313.52
- GAU $70.62
- Revenue Next Year
- RGNX N/A
- GAU $40.51
- P/E Ratio
- RGNX N/A
- GAU N/A
- Revenue Growth
- RGNX 80.70
- GAU 771.54
- 52 Week Low
- RGNX $5.04
- GAU $1.00
- 52 Week High
- RGNX $15.36
- GAU $2.00
- Technical
- Relative Strength Index (RSI)
- RGNX 49.21
- GAU 54.44
- Support Level
- RGNX $7.95
- GAU $1.31
- Resistance Level
- RGNX $11.00
- GAU $1.56
- Average True Range (ATR)
- RGNX 0.95
- GAU 0.08
- MACD
- RGNX -0.10
- GAU 0.01
- Stochastic Oscillator
- RGNX 28.52
- GAU 67.74
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About GAU Galiano Gold Inc.
Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages: Nkran, Esaase, Abore and Miradani North, multiple satellite deposits and exploration projects located on the Asankrangwa Gold Belt in the Amansie West District of the Republic of Ghana (Ghana), West Africa.